Global Markets for Therapeutic Botulinum Toxin 2009


November 1, 2008
SKU: MIL2581702
License type:
Table of Contents Related Reports
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 GLOBAL THERAPEUTIC BOTULINUM TOXIN MARKET
1.1 Market Overview
1.2 Market Analysis
1.2.1 Product Background
1.2.2 Procedure Overview
1.2.2.1 US Procedures
Cervical Dystonia Procedures
Blepharospasm Procedures
Strabismus Procedures
Severe Primary Axillary Hyperhidrosis
1.2.2.2 European Procedures
1.2.2.3 Japanese Procedures
1.2.2.4 Emerging Procedures
1.2.3 Market Forecast
1.2.3.1 US Therapeutic Botulinum Toxin Market
1.2.3.2 European Therapeutic Botulinum Toxin Market
1.2.3.3 Japanese Therapeutic Botulinum Toxin Market
1.2.4 Market Drivers and Limiters
1.2.4.1 Market Drivers
1.2.4.2 Market Limiters
1.3 Competitive Analysis
1.3.1 Leading Competitors
1.3.2 Emerging Competitors
2.0 US THERAPEUTIC BOTULINUM TOXIN MARKET
2.1 Market Overview
2.2 Market Analysis
2.2.1 Market Forecast
2.2.2 Market Drivers and Limiters
2.2.2.1 Market Drivers
2.2.2.2 Market Limiters
2.3 Competitive Analysis
2.3.1 Leading Competitors
2.3.2 Emerging Competitors
3.0 EUROPEAN THERAPEUTIC BOTULINUM TOXIN MARKET
3.1 Market Overview
3.2 Market Analysis
3.2.1 Market Forecast
3.2.2 Market Drivers and Limiters
3.2.2.1 Market Drivers
3.2.2.2 Market Limiters
3.3 Competitive Analysis
3.3.1 Leading Competitors
3.3.2 Emerging Competitors
4.0 JAPANESE THERAPEUTIC BOTULINUM TOXIN MARKET
4.1 Market Overview
4.2 Market Analysis
4.2.1 Market Forecast
4.2.2 Market Drivers and Limiters
4.2.2.1 Market Drivers
4.2.2.2 Market Limiters
4.3 Competitive Analysis
4.3.1 Leading Competitors
4.3.2 Emerging Competitors
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL EXHIBITS


LIST OF EXHIBITS

EXECUTIVE SUMMARY
Exhibit 1: Therapeutic BTX Market, Global (US$), 2007-2013
Exhibit 2: Therapeutic BTX Procedures, by Indication, US, as a % of Total, 2008 and 2013
Exhibit 3: Therapeutic BTX Market Units, Europe, 2007-2013
Exhibit 4: Therapeutic BTX Market, Japan (US$), 2007-2013
Exhibit 5: Leading Competitors in the Therapeutic BTX Market, Global, 2008


METHODOLOGY
Exhibit 6: Currency Exchange Rates, 2008


CHAPTER 1: GLOBAL THERAPEUTIC BOTULINUM TOXIN MARKET
Exhibit 7: Therapeutic BTX Market, by Country, Global (US$), 2007-2013 (Graphical Format)
Exhibit 8: Therapeutic BTX Product Overview, Global, 2008
Exhibit 9: Therapeutic BTX Procedures, by Country, Global, 2007-2013
Exhibit 10: Therapeutic BTX Procedures, by Procedure Type, US, 2007-2013
Exhibit 11: Therapeutic BTX Procedures, by Country, Europe, 2007-2013
Exhibit 12: Therapeutic BTX Procedures, Japan, 2007-2013
Exhibit 13: Therapeutic BTX Market, by Country, Global (US$), 2007-2013 (Tabular Format)
Exhibit 14: Therapeutic BTX Market, by Country, Global (€, £, and ¥), 2007-2013
Exhibit 15: Drivers and Limiters of the Therapeutic BTX Market, Global
Exhibit 16: Leading Competitors in the Therapeutic BTX Market, by Country, as a % of Total, Global, 2008


CHAPTER 2: US THERAPEUTIC BOTULINUM TOXIN MARKET
Exhibit 17: Therapeutic BTX Market, US (US$), 2007-2013 (Graphical Format)
Exhibit 18: Therapeutic BTX Market, US (US$), 2007-2013 (Tabular Format)
Exhibit 19: Therapeutic BTX Market Growth, US, 2008-2013
Exhibit 20: Drivers and Limiters of the Therapeutic BTX Market, US
Exhibit 21: Leading Competitors in the Therapeutic BTX Market, as a % of Total, US, 2008


CHAPTER 3: EUROPEAN THERAPEUTIC BOTULINUM TOXIN MARKET
Exhibit 22: Therapeutic BTX Market, by Country, Europe (US$), 2007-2013 (Graphical Format)
Exhibit 23: Therapeutic BTX Market, by Country, Europe (US$), 2007-2013 (Tabular Format)
Exhibit 24: Therapeutic BTX Market, by Country, Europe (€ and £), 2007-2013
Exhibit 25: Therapeutic BTX Market Growth, by Country, Europe, 2008-2013
Exhibit 26: Drivers and Limiters of the Therapeutic BTX Market, Europe
Exhibit 27: Leading Competitors in the Therapeutic BTX Market, by Country, as a % of Total, Europe, 2008


CHAPTER 4: JAPANESE THERAPEUTIC BOTULINUM TOXIN MARKET
Exhibit 28: Therapeutic BTX Market, Japan (US$), 2007-2013
Exhibit 29: Therapeutic BTX Market, Japan (US$ and ¥), 2007-2013
Exhibit 30: Therapeutic BTX Market Growth, Japan, 2008-2013
Exhibit 31: Drivers and Limiters of the Therapeutic BTX Market, Japan
Exhibit 32: Leading Competitors in the Therapeutic BTX Market, as a % of Total, Japan, 2008


APPENDIX B: SUPPLEMENTAL EXHIBITS
Exhibit 33: Therapeutic BTX Market, Global (US$), 2007-2013 (Detailed Format)
Exhibit 34: Therapeutic BTX Procedures, by Indication, US, as a % of Total, 2008 and 2013 (Detailed Format)
Exhibit 35: Therapeutic BTX Market Units, Europe, 2007-2013 (Detailed Format)
Exhibit 36: Therapeutic BTX Market, Japan (US$), 2007-2013 (Detailed Format)
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Prescription Drugs Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!